Understanding the current preclinical and clinical development landscape of cellular therapy for oncology and hematological malignancies.
A top 10 biotech company aimed to understand the current preclinical and clinical development landscape of cellular therapy for oncology and hematological malignancies in the UK and Ireland, and identify key research centers, researchers, and product development programs.
Our Solution
GlobalData leveraged its proprietary Pharma Intelligence Center databases to identify cancer cell therapy products in preclinical or clinical development in the UK and Ireland, clinical trials for these pipeline products, and relevant research centers and investigators in the region. Additional secondary and primary market research was performed, including interviews of key researchers in the cancer cell therapy space, to supplement database findings.
Outcome
GlobalData delivered robust mappings of clinical trials, research centers, and leading researchers, and a long list of preclinical and clinical cancer cell therapy products in the UK and Ireland, accompanied with GlobalData consultants’ insights through further secondary and primary research.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
